August 18, 2022 12:27 pm
Published by Fluidda
In a recently published systematic literature review, members of PVRI Innovative Drug Development Initiative’s Sequelae of COVID-19 Workstream, including Fluidda CEO Jan De Backer and CSO Ben Lavon, sought to... View Article
August 11, 2022 3:10 pm
Published by Fluidda
The potential of FRI in General Pulmonology “Technological advances have unleashed the potential to better treat prevalent lung diseases. Approaches like quantitative computerized tomography are increasingly used in routine care... View Article
August 4, 2022 12:09 pm
Published by Fluidda
FRI advances the patient care journey in Pulmonary Hypertension. “Innovative technologies are necessary to improve diagnosis and treatments in patients with pulmonary hypertension (PH). As a non-invasive tool that gives... View Article
July 28, 2022 3:57 pm
Published by Fluidda
FRI is the missing link for pulmonary vascular disease State Dr. Raymond L Benza of The Ohio State University and Dr. Mardi Gomberg-Maitland of George Washington University in a recent interview in... View Article
July 7, 2022 1:51 pm
Published by Fluidda
Broncholab™ is a platform where CT-scan data of individual persons can be uploaded and analysed with FRI-technology. The result of this analysis is then sent to the attending physician alone,... View Article
June 30, 2022 1:41 pm
Published by Fluidda
The Medimprove pulmonary rehabilitation facility, affiliated with Fluidda, is located in Kontich, Belgium.This interview with a COVID patient treated in this practice is therefore in Dutch language. Auteur: Patrick Marx... View Article
June 28, 2022 3:25 pm
Published by Fluidda
In June 2022, Fluidda obtained a CE Certificate for its Broncholab platform and can be used by physicians in all countries of the European Union, Iceland, Liechtenstein and Norway. Broncholab® provides a number of Functional Respiratory Imaging... View Article
June 16, 2022 2:24 pm
Published by Fluidda
We proudly present the third Fluidda Magazine on FRI technology. Several key opinion leaders explain in this issue how FRI helps them to optimize the diagnosis and therapy of lung patients with... View Article
June 9, 2022 2:14 pm
Published by Fluidda
Broncholab offers respiratory solutions to optimize treatment of individual lung patients Broncholab™, developed and implemented by Fluidda, is a platform where CT-scan data of individual persons can be uploaded and... View Article
May 31, 2022 1:28 pm
Published by Fluidda
On the 23rd of May, Jan De Backer – CEO of Fluidda had an interview with Edwin Warfield – CEO of Citybiz. Interview questions: Introduction | Please provide an introduction to... View Article